The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction

• DOI: 10.1073/pnas.0510041103
• Publication Date: 2006-04-08T00:34:18Z
• Authors: Daniel C. Rowe; Anne F. McGettrick; Eicke Latz; Brian G. Monks; Nicholas J. Gay; Masahiro Yamamoto; Shizuo Akira; Luke A. O’Neill; Katherine A. Fitz...; Douglas T. Golenbock
• Keywords: Lipopolysaccharides; 570; 0303 health sciences; Macrophages; Cell Membrane; Molecular Sequence Data; Bone Marrow Cells; Biochemistry; Myristic Acid; Mice, Mutant Strains; Toll-Like Receptor 4; Adaptor Proteins, Vesicular Transport; Mice; 03 medical and health sciences; Mutation; Animals; Humans; Amino Acid Sequence; Cells, Cultured; Signal Transduction

TRIF-related adaptor molecule (TRAM) is the fourth Toll/IL-1 resistance domain-containing adaptor to be described that participates in Toll-like receptor (TLR) signaling. TRAM functions exclusively in the TLR4 pathway. Here we show by confocal microscopy that TRAM is localized in the plasma membrane and the Golgi apparatus, where it colocalizes with TLR4. Membrane localization of TRAM is the result of myristoylation because mutation of a predicted myristoylation site in TRAM (TRAM-G2A) brought about dissociation of TRAM from the membrane and its relocation to the cytosol. Further, TRAM, but not TRAM-G2A, was radiolabeled with [ 3 H]myristate in vivo . Unlike wild-type TRAM, overexpression of TRAM-G2A failed to elicit either IFN regulatory factor 3 or NF-κB signaling. Moreover, TRAM-G2A was unable to reconstitute LPS responses in bone marrow-derived macrophages from TRAM-deficient mice. These observations provide clear evidence that the myristoylation of TRAM targets it to the plasma membrane, where it is essential for LPS responses through the TLR4 signal transduction pathway, and suggest a hitherto unappreciated manner in which LPS responses can be regulated.